The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABEONA THERAPEUTICS INC | COM | 00289Y107 | 2,944 | 400,000 | SH | DFND | 1 | 400,000 | 0 | 0 | |
ACCELERON PHARMA INC | COM | 00434H108 | 1,863 | 40,000 | SH | DFND | 1 | 40,000 | 0 | 0 | |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 2,519 | 420,555 | SH | DFND | 1 | 420,555 | 0 | 0 | |
ALLAKOS INC | COM | 01671P100 | 30,375 | 750,000 | SH | DFND | 1 | 750,000 | 0 | 0 | |
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 12,456 | 600,000 | SH | DFND | 1 | 600,000 | 0 | 0 | |
ANAPTYSBIO INC | COM | 032724106 | 67,206 | 920,000 | SH | DFND | 1 | 920,000 | 0 | 0 | |
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 70,200 | 3,600,000 | SH | DFND | 1 | 3,600,000 | 0 | 0 | |
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 11,207 | 250,000 | SH | DFND | 1 | 250,000 | 0 | 0 | |
ARGENX SE | SPONSORED ADR | 04016X101 | 34,331 | 275,000 | SH | DFND | 1 | 275,000 | 0 | 0 | |
ARRAY BIOPHARMA INC | COM | 04269X105 | 12,190 | 500,000 | SH | DFND | 1 | 500,000 | 0 | 0 | |
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 70,620 | 600,000 | SH | DFND | 1 | 600,000 | 0 | 0 | |
ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 21,863 | 550,000 | SH | DFND | 1 | 550,000 | 0 | 0 | |
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 3,902 | 100,000 | SH | DFND | 1 | 100,000 | 0 | 0 | |
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 26,750 | 850,000 | SH | DFND | 1 | 850,000 | 0 | 0 | |
AVROBIO INC | COM | 05455M100 | 6,615 | 300,000 | SH | DFND | 1 | 300,000 | 0 | 0 | |
AXONICS MODULATION TECH INC | COM | 05465P101 | 30,477 | 1,272,495 | SH | DFND | 1 | 1,272,495 | 0 | 0 | |
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 56,617 | 1,100,000 | SH | DFND | 1 | 1,100,000 | 0 | 0 | |
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 36,023 | 450,000 | SH | DFND | 1 | 450,000 | 0 | 0 | |
CELLECTAR BIOSCIENCES-CW19 | *W EXP 08/20/201 | 15117F120 | 5 | 52,999 | SH | DFND | 1 | 52,999 | 0 | 0 | |
CHEMOCENTRYX INC | COM | 16383L106 | 35,085 | 2,525,900 | SH | DFND | 1 | 2,525,900 | 0 | 0 | |
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 3,028 | 200,000 | SH | DFND | 1 | 200,000 | 0 | 0 | |
CONSTELLATION PHARMACEUTICALS I | COM | 210373106 | 17,231 | 1,271,687 | SH | DFND | 1 | 1,271,687 | 0 | 0 | |
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 32,148 | 900,000 | SH | DFND | 1 | 900,000 | 0 | 0 | |
EIDOS THERAPEUTICS INC | COM | 28249H104 | 11,902 | 507,564 | SH | DFND | 1 | 507,564 | 0 | 0 | |
GALAPAGOS NV | SPON ADR | 36315X101 | 34,965 | 300,000 | SH | DFND | 1 | 300,000 | 0 | 0 | |
GENFIT S A | ADS | 372279109 | 8,400 | 350,000 | SH | DFND | 1 | 350,000 | 0 | 0 | |
GOSSAMER BIO INC | COM | 38341P102 | 14,153 | 653,129 | SH | DFND | 1 | 653,129 | 0 | 0 | |
HARPOON THERAPEUTICS INC | COM | 41358P106 | 6,382 | 673,891 | SH | DFND | 1 | 673,891 | 0 | 0 | |
HERON THERAPEUTICS INC | COM | 427746102 | 3,666 | 150,000 | SH | DFND | 1 | 150,000 | 0 | 0 | |
INCYTE CORP | COM | 45337C102 | 2,580 | 30,000 | SH | DFND | 1 | 30,000 | 0 | 0 | |
INFLARX NV | COM | N44821101 | 97,876 | 2,590,000 | SH | DFND | 1 | 2,590,000 | 0 | 0 | |
INSPIRE MED SYS INC | COM | 457730109 | 14,195 | 250,000 | SH | DFND | 1 | 250,000 | 0 | 0 | |
ITERUM THERAPEUTICS PLC | SHS | G6333L101 | 3,198 | 398,300 | SH | DFND | 1 | 398,300 | 0 | 0 | |
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 23,062 | 1,300,000 | SH | DFND | 1 | 1,300,000 | 0 | 0 | |
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 4,876 | 270,000 | SH | DFND | 1 | 270,000 | 0 | 0 | |
KURA ONCOLOGY INC | COM | 50127T109 | 23,226 | 1,400,000 | SH | DFND | 1 | 1,400,000 | 0 | 0 | |
MINERVA NEUROSCIENCES INC | COM | 603380106 | 4,778 | 607,903 | SH | DFND | 1 | 607,903 | 0 | 0 | |
MIRATI THERAPEUTICS INC | COM | 60468T105 | 78,798 | 1,075,000 | SH | DFND | 1 | 1,075,000 | 0 | 0 | |
MYOKARDIA INC | COM | 62857M105 | 31,194 | 600,000 | SH | DFND | 1 | 600,000 | 0 | 0 | |
MYOVANT SCIENCES LTD | COM | G637AM102 | 15,516 | 650,000 | SH | DFND | 1 | 650,000 | 0 | 0 | |
NEKTAR THERAPEUTICS | COM | 640268108 | 16,800 | 500,000 | SH | DFND | 1 | 500,000 | 0 | 0 | |
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 7,929 | 90,000 | SH | DFND | 1 | 90,000 | 0 | 0 | |
ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 11,628 | 650,143 | SH | DFND | 1 | 650,143 | 0 | 0 | |
OUTLOOK THERAPEUTICS INC | *W EXP 02/18/202 | 69012T115 | 150 | 416,666 | SH | DFND | 1 | 416,666 | 0 | 0 | |
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 7,985 | 839,642 | SH | DFND | 1 | 839,642 | 0 | 0 | |
PRECISION BIOSCIENCES INC | COM | 74019P108 | 14,001 | 780,018 | SH | DFND | 1 | 780,018 | 0 | 0 | |
PRINCIPIA BIOPHARMA INC | COM | 74257L108 | 48,005 | 1,411,898 | SH | DFND | 1 | 1,411,898 | 0 | 0 | |
QUOTIENT LTD | SHS | G73268107 | 41,446 | 4,600,000 | SH | DFND | 1 | 4,600,000 | 0 | 0 | |
RA PHARMACEUTICALS INC | COM | 74933V108 | 8,960 | 400,000 | SH | DFND | 1 | 400,000 | 0 | 0 | |
REATA PHARMACEUTICALS INC-A | CL A | 75615P103 | 52,564 | 615,000 | SH | DFND | 1 | 615,000 | 0 | 0 | |
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 29,818 | 1,700,000 | SH | DFND | 1 | 1,700,000 | 0 | 0 | |
RUBIUS THERAPEUTICS INC | COM | 78116T103 | 11,765 | 650,000 | SH | DFND | 1 | 650,000 | 0 | 0 | |
SAGE THERAPEUTICS INC | COM | 78667J108 | 20,677 | 130,000 | SH | DFND | 1 | 130,000 | 0 | 0 | |
SAREPTA THERAPEUTICS INC | COM | 803607100 | 35,757 | 300,000 | SH | DFND | 1 | 300,000 | 0 | 0 | |
SCHOLAR ROCK HLDG CORP | COM | 80706P103 | 3,361 | 178,891 | SH | DFND | 1 | 178,891 | 0 | 0 | |
SOLID BIOSCIENCES INC | COM | 83422E105 | 2,300 | 250,000 | SH | DFND | 1 | 250,000 | 0 | 0 | |
TRANSLATE BIO INC | COM | 89374L104 | 4,632 | 454,549 | SH | DFND | 1 | 454,549 | 0 | 0 | |
TRICIDA INC | COM | 89610F101 | 38,990 | 1,009,586 | SH | DFND | 1 | 1,009,586 | 0 | 0 | |
TWIST BIOSCIENCE CORP | COM | 90184D100 | 16,367 | 706,064 | SH | DFND | 1 | 706,064 | 0 | 0 | |
X4 PHARMACEUTICALS INC | COM | 98420X103 | 4,400 | 252,749 | SH | DFND | 1 | 252,749 | 0 | 0 | |
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 83,750 | 925,000 | SH | Put | DFND | 1 | 925,000 | 0 | 0 |
Y-MABS THERAPEUTICS INC | COM | 984241109 | 18,753 | 715,482 | SH | DFND | 1 | 715,482 | 0 | 0 | |
ZAI LAB LTD | ADR | 98887Q104 | 10,328 | 350,000 | SH | DFND | 1 | 350,000 | 0 | 0 | |
ZOGENIX INC | COM NEW | 98978L204 | 24,755 | 450,000 | SH | DFND | 1 | 450,000 | 0 | 0 |